Evaluation of the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
This is a prospective, single-center, single-arm Phase II study evaluating the efficacy of the myDIET software tool in the nutritional management of patients with localized and resectable esogastric junction cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient 18 years of age or older at date of signing informed consent to participate;
• Histologically proven diagnosis of gastric adenocarcinoma or OGJ;
• Localized, resectable disease;
• Patient treated with perioperative Oxaliplatin-based chemotherapy,
• Performance status (ECOG): 0-2;
• Membership of a social security scheme;
• Signed informed consent to participate.
Locations
Other Locations
France
Centre Léon Berard
RECRUITING
Lyon
Contact Information
Primary
Pamela Funk-Debleds, MD
pamela.funk-debleds@lyon.unicancer.fr
0469856020
Backup
Clélia Coutzac, MD
clelia.coutzac@lyon.unicancer.fr
0469856020
Time Frame
Start Date: 2024-04-26
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 60
Treatments
Experimental: use of myDIET tool for nutritional management
Patients will be followed up at regular intervals during neoadjuvant chemotherapy, perioperatively and up to 6 months after the date of surgery (after completion of postoperative chemotherapy).
Related Therapeutic Areas
Sponsors
Leads: Centre Leon Berard